Neural Cell News 14.16 April 29, 2020 | |
| |
TOP STORYDisease-Associated Astrocytes in Alzheimer’s Disease and Aging Using single-nucleus RNA sequencing, scientists identified a population of disease-associated astrocytes in an Alzheimer’s disease mouse model. These disease-associated astrocytes appeared at early disease stages and increased in abundance with disease progression. [Nat Neurosci] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Dynamic Fas Signaling Network Regulates Neural Stem Cell Proliferation and Memory Enhancement Fas activation in immature neurons of the dentate gyrus triggered mammalian target of rapamycin activation and subsequent brain-derived neurotrophic factor secretion. [Sci Adv] Full Article Using multiple in vitro and preclinical animal models of glioma and cholangiocarcinoma, researchers developed treatment strategies that used a synthetic lethality approach targeting the reduced DNA damage repair conferred by mutant isocitrate dehydrogenase (IDH) using poly ribose polymerase inhibitors. [Sci Adv] Full Article Investigators adapted a system to induce neural progenitor cell development from mouse embryonic stem cell lines deficient for XRCC4 plus p53, a genotype that enhanced DNA double-strand break persistence to enhance detection. [Proc Natl Acad Sci USA] Abstract Excitatory cortical neurons with high heteroplasmy exhibited mitochondrial dysfunction, delayed neural maturation, reduced dendritic complexity, and fewer excitatory synapses. [Cell Rep] Full Article | Graphical Abstract Screening of molecules involved in this accumulation of microglia to axons of layer V cortical neurons identified netrin-G1. Deletion or knockdown of the netrin-G1 gene Ntng1 reduced microglial accumulation and caused loss of cortical neurons. [Cell Rep] Full Article | Graphical Abstract The authors investigated how chemokines affected temozolomide (TMZ)-promoted cellular dormancy entry and exit in glioblastoma cells. TMZ administration over ten days promoted cellular dormancy entry, whereas discontinuing TMZ for a further 15 days resulted in resumption of proliferation. [Oncogene] Full Article Local Ca2+ Signals Couple Activation of TRPV1 and ANO1 Sensory Ion Channels Scientists revealed an intricate mechanism of TRPV1-ANO1 channel coupling in rat dorsal root ganglion neurons. Simultaneous optical monitoring of Ca2+-activated Cl– channel (CaCC) activity and Ca2+ dynamics revealed that the TRPV1 ligand capsaicin activated CaCCs. [Sci Signal] Abstract Modeling Human CNS Injury with Human Neural Stem Cells in 2- and 3-Dimensional Cultures The authors developed human neural stem cell 3D cultures and tested their potential for modeling neural insults, including hypoxic-ischaemic and Ca2+-dependent injury. [Sci Rep] Full Article N-Myc-Induced Metabolic Rewiring Creates Novel Therapeutic Vulnerabilities in Neuroblastoma Investigators describe the effects of N-Myc overexpression on metabolic reprogramming in neuroblastoma cells. Ectopic expression of N-Myc induced a glycolytic switch that was concomitant with enhanced sensitivity towards 2-deoxyglucose, an inhibitor of glycolysis. [Sci Rep] Full Article Subscribe to one of our other 19 science newsletters such as Cancer Stem Cell News & ESC & iPSC News. | |
| |
REVIEWSThe authors provide an overview on the role of microglia in human neurodegenerative diseases and provide an update on the current model systems to study microglia. [Prog Neurobiol] Full Article Visit our reviews page to see a complete list of reviews in the neural cell research field. | |
| |
INDUSTRY NEWSAskBio Acquires BrainVectis to Expand its Clinical Pipeline for Neurodegenerative Diseases Asklepios BioPharmaceutical, Inc. announced that it has acquired BrainVectis, a Paris-based gene therapy company and French National Institute for Health and Medical Research spin-out with expertise and an intellectual property estate for the treatment of neurodegenerative disorders. [Asklepios BioPharmaceutical, Inc.] Press Release NOXXON Pharma N.V. announced that an independent Data Safety Monitoring Board has confirmed that it is safe to start patient recruitment for the middle dose cohort for the Phase I/II NOX-A12 plus radiotherapy brain cancer trial. [NOXXON Pharma N.V.] Press Release | |
| |
POLICY NEWSAs COVID-19 Forces Conferences Online, Scientists Discover Upsides of Virtual Format As the novel coronavirus outbreak shutters businesses and disrupts everyday life for billions around the globe, massive annual conferences and small society meetings alike have moved online. The new format poses numerous technical and organizational challenges, but it also offers opportunities- for reaching wider audiences, reducing the carbon footprint of meeting travel, and improving diversity and equity. [ScienceInsider] Editorial Open Science Takes On the Coronavirus Pandemic When reports emerged in late 2019 of an outbreak of a new coronavirus centred in Wuhan, China, researchers at the virological-analysis website Nextstrain were ready. The open-source project tracks the spread of viruses through genetic variations in the sequences that scientists find. [Nature News] Editorial
| |
EVENTSIn light of COVID-19, many conferences are being cancelled or postponed. As such: We are suspending new event postings in our newsletters and on Twitter. Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Position – Neuroscience (Linköping University) NEW Associate Professor – Molecular Neurobiology (Aarhus University) Professorship – Molecular Neuropathology (Ludwig-Maximilians-Universität München) Researcher Position – Transcriptional Activity in Brain Diseases (Italian Institute of Technology) Postdoctoral Position – Brain and Disease Research (Flanders Institute for Biotechnology) Postdoctoral Fellow – Neurogenerative Disease (Johns Hopkins University School of Medicine) Scientist – Oligonucleotide Therapies for Neurological Disorders (Deep Genomics Inc.) Postdoctoral Position – Neuroimmunology (LMU University Hospital Munich) Postdoctoral Position – iPSC Models in Neurodegeneration (Flanders Institute for Biotechnology) Postdoctoral Fellow – Developmental Neuroscience (Children’s National Hospital) Research Assistant – Cerebral Organoids (Weill Cornell Medicine College) Faculty Positions – Brain Disorders (IDG/McGovern Institute for Brain Research) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Neural Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|